(PHILADELPHIA) – Daniel Sterman, MD, director of Interventional Pulmonology, and associate professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, has been honored with the Pasquale Ciaglia Memorial Lecture award in Interventional Medicine. He received this recognition at the 2011 International Scientific Assembly of the American College of Chest Physicians (ACCP).
"I am honored and humbled to be the 2011 recipient of the Pasquale Ciaglia Memorial Lectureship," said Dr. Sterman. "Dr. Ciaglia was a pioneering and innovative thoracic surgeon who lived in my home community of upstate New York, and was a role model for all those interested in providing care for patients with critical illnesses and thoracic malignancies. As Dr. Ciaglia was also a great humanitarian, I will also try to emulate this aspect of his life."
The Pasquale Ciaglia Memorial Lecture in Interventional Medicine, awarded by the ACCP, honors physicians well known for his or her work in interventional medicine, including economic impact, research opportunities, and critical care.
Dr. Sterman's clinical interests are related to the treatment of thoracic malignancies, specifically as they apply to the synergy of molecular medicine and novel technologies in Interventional Pulmonology. His research interests are in the translation of laboratory discoveries from the bench to the bedside: conducting human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies. Dr. Sterman is also the co-director of the Penn Medicine Mesothelioma and Pleural Program.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.